This differential progression pattern may reflect distinct underlying pathophysiological mechanisms, with myotonia primarily resulting from altered chloride channel function due to DMPK gene effects, while weakness stems from progressive muscle fiber degeneration and replacement. The gene discussed is DMPK; the disease is Myotonia.